Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionEP Wealth Advisors, Inc.
Latest Disclosed Ownership26,970 shares
Latest Disclosed Value $ 3,758,767
EP Wealth Advisors, Inc. reports 4.67% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 14, 2026 - EP Wealth Advisors, Inc. filed a 13F-HR form disclosing ownership of 26,970 shares of Gilead Sciences, Inc. (US:GILD) valued at $3,758,809 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 28,291 shares of Gilead Sciences, Inc.. This represents a change in shares of -4.67% during the quarter. The current value of the position is $3,483,445 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GILEAD SCIENCES COM 375558103 26,970 -1,321 -4.67 3,759 8.24 0.0185
2026-02-18 2025-12-31 13F GILEAD SCIENCES COM 375558103 28,291 -965 -3.30 3,472 7.06 0.0180
2025-08-14 2025-06-30 13F Gilead Sciences COM 375558103 29,256 1,672 6.06 3,244 4.95 0.0213
2025-05-15 2025-03-31 13F GILEAD SCIENCES COM 375558103 27,584 -1,720 -5.87 3,091 14.19 0.0247
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 29,304 -24,647 -45.68 2,707 -40.17 0.0221
2024-11-15 2024-09-30 13F GILEAD SCIENCES COM 375558103 53,951 6,492 13.68 4,523 38.91 0.0389
2024-08-19 2024-06-30 13F Gilead Sciences COM 375558103 47,459 527 1.12 3,256 -5.27 0.0346
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 46,932 -534 -1.13 3,438 -10.61 0.0402
2024-02-28 2023-12-31 13F Gilead Sciences COM 375558103 47,466 356 0.76 3,845 8.92 0.0490
2023-11-24 2023-09-30 13F GILEAD SCIENCES COM 375558103 47,110 6,560 16.18 3,530 31.32 0.0548
2023-08-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 40,550 -19,450 -32.42 2,689 0.0388
2023-06-05 2023-03-31 13F GILEAD SCIENCES COM 375558103 60,000 52,661 717.55 0 -100.00 0.0000
2023-06-12 2022-12-31 13F GILEAD SCIENCES COM 375558103 7,339 7,339 630 0.0114
2022-12-02 2022-09-30 13F GILEAD SCIENCES COM 375558103 0 -8,124 -100.00 0 -100.00
2022-08-11 2022-06-30 13F GILEAD SCIENCES COM 375558103 8,124 2,944 56.83 502 62.99 0.0113
2022-05-20 2022-03-31 13F GILEAD SCIENCES COM 375558103 5,180 -408 -7.30 308 -24.14 0.0068
2022-02-17 2021-12-31 13F GILEAD SCIENCES COM 375558103 5,588 979 21.24 406 26.09 0.0096
2021-11-23 2021-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 4,609 -340 -6.87 322 -5.57 0.0088
2021-11-16 2021-09-30 13F GILEAD SCIENCES COM 375558103 3,613,253 3,608,304 322 0.0088
2021-08-24 2021-06-30 13F GILEAD SCIENCES COM 375558103 4,949 -171 -3.34 341 3.02 0.0095
2021-05-17 2021-03-31 13F GILEAD SCIENCES COM 375558103 5,120 5,120 3.46 331 -2.93 0.0105
2021-02-18 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -4,047 -100.00 0 -100.00
2020-11-17 2020-09-30 13F GILEAD SCIENCES COM 375558103 4,047 151 3.88 256 -14.67 0.0110
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 3,896 -1,647 -29.71 300 -27.54 0.0128
2020-05-18 2020-03-31 13F GILEAD SCIENCES COM 375558103 5,543 1,692 43.94 414 65.60 0.0203
2020-02-14 2019-12-31 13F GILEAD SCIENCES COM 375558103 3,851 -753 -16.36 250 -14.38 0.0103
2019-11-18 2019-09-30 13F GILEAD SCIENCES COM 375558103 4,604 394 9.36 292 2.82 0.0145
2019-08-27 2019-06-30 13F GILEAD SCIENCES COM 375558103 4,210 -1,020 -19.50 284 -16.47 0.0177
2019-05-20 2019-03-31 13F GILEAD SCIENCES COM 375558103 5,230 242 4.85 340 8.97 0.0327
2019-02-15 2018-12-31 13F GILEAD SCIENCES COM 375558103 4,988 -38 -0.76 312 -19.59 0.0241
2018-11-15 2018-09-30 13F GILEAD SCIENCES COM 375558103 5,026 5,026 0.76 388 24.36 0.0303
2015-05-15 2015-03-31 13F Gilead Sciences Common 375558103 0 -67,327 -100.00 0 -100.00
2015-02-17 2014-12-31 13F Gilead Sciences Common 375558103 67,327 459 0.69 6,346 -10.85 1.0458
2014-11-12 2014-09-30 13F Gilead Sciences Common 375558103 66,868 -51,192 -43.36 7,118 -27.28 1.1527
2014-07-25 2014-06-30 13F Gilead Sciences Common 375558103 118,060 4,757 4.20 9,788 21.91 2.2746
2014-05-15 2014-03-31 13F GileadSciencesInc Common 375558103 113,303 -8,611 -7.06 8,029 -12.31 2.1960
2014-02-14 2013-12-31 13F Gilead Sciences Common 375558103 121,914 -1,510 -1.22 9,156 17.99 2.3747
2013-11-14 2013-09-30 13F Gilead Sciences Common 375558103 123,424 -10,442 -7.80 7,760 13.07 2.4382
2013-08-14 2013-06-30 13F Gilead Sciences Common 375558103 133,866 133,866 6,863 2.4761
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.